Global Industrial Hemp in Medical
Market Report
2025
The global industrial hemp in medical market size will be USD XX million in 2024. Growing acceptance of hemp-based products for medical purposes is expected to boost sales to USD XX million by 2031, with a Compound Annual Growth Rate (CAGR) of 18.50% from 2024 to 2031.
The base year for the calculation is 2024. The historical will be 2021 to 2024. The year 2025 will be estimated one while the forecasted data will be from year 2025 to 2033. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
Share your contact details to receive free updated sample copy/pages of the recently published edition of Industrial Hemp in Medical Market Report 2025.
According to Cognitive Market Research, the global industrial hemp in medical market size will be USD XX million in 2024. It will expand at a compound annual growth rate (CAGR) of 18.50% from 2024 to 2031.
2021 | 2025 | 2033 | CAGR | |
---|---|---|---|---|
Global Industrial Hemp in Medical Market Sales Revenue | 121212 | 121212 | 121212 | 18.5% |
North America Industrial Hemp in Medical Market Sales Revenue | 121212 | 121212 | 121212 | 16.7% |
United States Industrial Hemp in Medical Market Sales Revenue | 121212 | 121212 | 121212 | 16.5% |
Canada Industrial Hemp in Medical Market Sales Revenue | 121212 | 121212 | 121212 | 17.5% |
Mexico Industrial Hemp in Medical Market Sales Revenue | 121212 | 121212 | 121212 | 17.2% |
Europe Industrial Hemp in Medical Market Sales Revenue | 121212 | 121212 | 121212 | 17% |
United Kingdom Industrial Hemp in Medical Market Sales Revenue | 121212 | 121212 | 121212 | 17.8% |
France Industrial Hemp in Medical Market Sales Revenue | 121212 | 121212 | 121212 | 16.2% |
Germany Industrial Hemp in Medical Market Sales Revenue | 121212 | 121212 | 121212 | 17.2% |
Italy Industrial Hemp in Medical Market Sales Revenue | 121212 | 121212 | 121212 | 16.4% |
Russia Industrial Hemp in Medical Market Sales Revenue | 121212 | 121212 | 121212 | 16% |
Spain Industrial Hemp in Medical Market Sales Revenue | 121212 | 121212 | 121212 | 16.1% |
Rest of Europe Industrial Hemp in Medical Market Sales Revenue | 121212 | 121212 | 121212 | 15.7% |
Asia Pacific Industrial Hemp in Medical Market Sales Revenue | 121212 | 121212 | 121212 | 20.5% |
China Industrial Hemp in Medical Market Sales Revenue | 121212 | 121212 | 121212 | 20% |
Japan Industrial Hemp in Medical Market Sales Revenue | 121212 | 121212 | 121212 | 19% |
India Industrial Hemp in Medical Market Sales Revenue | 121212 | 121212 | 121212 | 22.3% |
South Korea Industrial Hemp in Medical Market Sales Revenue | 121212 | 121212 | 121212 | 19.6% |
Australia Industrial Hemp in Medical Market Sales Revenue | 121212 | 121212 | 121212 | 20.2% |
Rest of APAC Industrial Hemp in Medical Market Sales Revenue | 121212 | 121212 | 121212 | 20.3% |
South America Industrial Hemp in Medical Market Sales Revenue | 121212 | 121212 | 121212 | 17.9% |
Brazil Industrial Hemp in Medical Market Sales Revenue | 121212 | 121212 | 121212 | 18.5% |
Argentina Industrial Hemp in Medical Market Sales Revenue | 121212 | 121212 | 121212 | 18.8% |
Colombia Industrial Hemp in Medical Market Sales Revenue | 121212 | 121212 | 121212 | 17.7% |
Peru Industrial Hemp in Medical Market Sales Revenue | 121212 | 121212 | 121212 | 18.1% |
Chile Industrial Hemp in Medical Market Sales Revenue | 121212 | 121212 | 121212 | 18.2% |
Rest of South America Industrial Hemp in Medical Market Sales Revenue | 121212 | 121212 | 121212 | 17% |
Middle East Industrial Hemp in Medical Market Sales Revenue | 121212 | 121212 | 121212 | 18.2% |
Egypt Industrial Hemp in Medical Market Sales Revenue | 121212 | 121212 | 121212 | 18.5% |
Turkey Industrial Hemp in Medical Market Sales Revenue | 121212 | 121212 | 121212 | 17.7% |
Rest of Middle East Industrial Hemp in Medical Market Sales Revenue | 121212 | 121212 | 121212 | 17.2% |
Base Year | 2024 |
Historical Data Time Period | 2021-2024 |
Forecast Period | 2025-2033 |
Market Split by Source Outlook: |
|
List of Competitors |
|
Regional Analysis |
|
Country Analysis |
|
Market Drivers:
| |
Market Restrains:
| |
Market Trends:
|
Report scope is customizable as we have a huge database of Industrial Hemp in Medical industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Industrial Hemp in Medical Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Industrial hemp is a variety of Cannabis sativa cultivated for its fibers, seeds, and other components, primarily for medical use. Its seeds are rich in protein and omega-3 fatty acids, while fibers are used for their medicinal benefits. Shivs, a by-product of fiber production, are utilized in various healthcare applications. Industrial hemp offers significant benefits in medical treatments due to its low THC content, ensuring it doesn’t cause psychoactive effects. The plant is increasingly used in products aimed at treating various ailments, such as insomnia, pain, and as an adjunct to anesthesia, due to its therapeutic potential.
In December 2022, InterCure Ltd., an Israel-based medical cannabis cultivation company, finalized a licensing agreement with Binske, a U.S.-based cannabis firm. Under the terms of the agreement, InterCure Ltd. will have exclusive multi-year rights to market, distribute, and manufacture Binske-branded products in pharmaceutical markets, including Australia, the U.K., Israel, and Germany. (Source: https://mayafiles.tase.co.il/rpdf/1515001-1516000/P1515567-00.pdf)
The growing acceptance of hemp-based products in the medical field is a key driver of market expansion. As research continues to validate the therapeutic benefits of hemp, especially cannabidiol (CBD), its acceptance among healthcare providers and consumers is increasing. Hemp is increasingly recognized for its efficacy in managing pain, reducing inflammation, and treating anxiety and sleep disorders, without the psychoactive effects of THC. Governments are also easing regulations, facilitating wider availability of hemp-based medicines. In 2024, several countries, including the U.S. and Canada, have fully legalized hemp-derived products for medical use, further promoting their mainstream adoption. This shift is bolstered by growing consumer preference for natural, plant-based treatments, contributing to a robust market outlook for hemp in the medical sector. The expanding body of evidence supporting hemp’s health benefits is fueling further demand for hemp-based remedies worldwide.
The increasing number of research initiatives and clinical trials focusing on hemp’s medical applications is a significant factor driving market growth. Studies exploring hemp’s potential in treating chronic pain, anxiety, sleep disorders, and even neurological conditions are generating substantial interest in its therapeutic uses. In 2024, several new trials are underway, investigating hemp’s role in managing cancer-related symptoms, neurological diseases, and post-traumatic stress disorder (PTSD). The expanding clinical evidence is establishing hemp as a legitimate alternative to traditional pharmaceuticals, especially in pain management and mental health. As more successful trials emerge, regulatory authorities are more likely to approve hemp-based therapies, leading to broader market access and consumer acceptance. This growing body of evidence supports the development of more innovative hemp-based medicines, further accelerating market expansion and adoption.
Inconsistent product quality and potency are significant barriers limiting the growth of the industrial hemp medical market. Variability in hemp cultivation practices, extraction methods, and manufacturing processes can lead to products with inconsistent concentrations of active compounds like CBD. This inconsistency undermines consumer confidence and creates challenges for healthcare providers in prescribing accurate doses. Furthermore, lack of standardization across the industry results in varying levels of effectiveness, which can lead to negative experiences for patients relying on hemp-based treatments. As a result, regulatory bodies are under pressure to establish more stringent quality control measures. Until these issues are addressed through better regulation and improved manufacturing practices, inconsistent product quality will continue to hinder market growth and slow widespread acceptance of hemp-based medical solutions.
The COVID-19 pandemic negatively impacted the industrial hemp in the medical market. Disruptions in global supply chains, along with regulatory hurdles, delayed production and distribution of hemp-based medical products. During the initial phase of the pandemic, many research projects and clinical trials were either paused or postponed, slowing down the development of new hemp-based therapies. Moreover, healthcare systems were focused on managing the pandemic, leading to reduced focus on alternative medical treatments. Although demand for wellness products surged, logistical challenges and concerns about the availability of raw materials led to price fluctuations and product shortages, limiting growth in the short term. The market is expected to recover gradually as global restrictions ease and consumer confidence returns.
We have various report editions of Industrial Hemp in Medical Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
The reintroduction of tariffs under President Trump’s “Liberation Day Tariffs” in April 2025 has created significant disruption in global pharmaceutical trade. These tariffs, ranging from 10% to 46%, specifically target pharmaceutical products, APIs (active pharmaceutical ingredients), medical packaging, and machinery from key manufacturers in China and India. This has led to increased production costs, supply chain delays, and regulatory challenges for U.S.-based pharmaceutical companies.
The tariffs have particularly impacted generic drug manufacturers, who rely heavily on APIs from China and India. Biopharmaceuticals and vaccines are also feeling the pressure, with tariffs on critical materials like bioproduction media and cold-chain packaging raising costs by up to 25%. Similarly, contract manufacturing organizations (CMOs) are grappling with the need to identify new suppliers and adjust production plans to mitigate rising costs.
Foreign governments, including the European Union, have retaliated with tariffs on U.S. pharmaceutical exports, further complicating global trade. Clinical trials are also impacted, as tariffs on drugs and diagnostic kits delay trial timelines.
Market research is increasingly crucial for navigating these challenges. By providing real-time data on API pricing, supplier reliability, and tariff impact, pharmaceutical firms can make informed decisions on sourcing, compliance, and investment strategies. This data-driven approach helps mitigate risks, optimize supply chains, and identify alternative manufacturing hubs to offset tariff-related disruptions.
Overall, market research is essential for pharmaceutical companies to adapt to the new tariff landscape, enabling them to maintain competitive advantage and navigate global trade dynamics effectively.
The industrial hemp medical market is competitive, with several global players investing heavily in product innovation, research, and marketing. Companies like Charlotte’s Web, Canopy Growth, and Tilray dominate the market, leveraging their extensive distribution networks and brand recognition. Smaller companies focus on niche applications, such as targeted CBD products for pain relief and insomnia. The competitive landscape is marked by collaborations, mergers, and acquisitions as companies look to expand their product portfolios and increase market penetration.
In January 2023, Bast Fibre Technologies Inc. (BFT), a Canadian producer of natural fibers, acquired Lumberton Cellulose LLC, a natural fiber processing facility located in North Carolina, U.S. The acquisition is expected to enhance BFT's manufacturing capabilities in North America, enabling the company to meet the increasing demand for sustainable natural fibers. (Source: https://www.canadianmanufacturing.com/manufacturing/bast-fibre-technologies-to-acquire-lumberton-cellulose-llc-277562/) In September 2022, the Thai Industrial Hemp Trade Association (TIHTA) entered into a cooperation agreement with twelve manufacturing associations to highlight technology and innovations in the hemp industry. According to TIHTA, the partnership will improve access to higher-quality raw materials, foster networking opportunities, and facilitate knowledge sharing, all aimed at positioning Thailand as Asia's leading hub for hemp industries. (Source: https://hemphealth.co.uk/thai-hemp-association-tihta-signs-pact-agreements-with-12-leading-manufacturing-industries/)
Top Companies Market Share in Industrial Hemp in Medical Industry: (In no particular order of Rank)
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
According to Cognitive Market Research, North America is the leading region in the industrial hemp medical market, driven by favorable legal frameworks and an increasing number of states legalizing hemp for medicinal purposes. The U.S. market, in particular, has witnessed substantial growth in hemp-derived CBD products, including oils, tinctures, and capsules. Strong demand for hemp-based therapies, particularly in pain management and sleep disorders, contributes to North America's dominance. Leading companies in the region continue to expand product offerings to meet growing consumer needs.
Asia-Pacific is the fastest-growing region in the industrial hemp medical market, with countries like China, India, and Australia leading the way. The region is witnessing a surge in demand for hemp-based products due to increasing awareness of their therapeutic benefits. Regulatory changes are making it easier for hemp cultivation and production to expand, while growing consumer interest in natural health products accelerates market growth. As more countries legalize industrial hemp for medical use, the Asia-Pacific region is expected to experience rapid market expansion.
The current report Scope analyzes Industrial Hemp in Medical Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
According to Cognitive Market Research, the global industrial hemp in medical market size was estimated at USD XX Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 16.7% from 2024 to 2031.
According to Cognitive Market Research, the global industrial hemp in medical market size was estimated at USD XX Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 17.0% from 2024 to 2031.
According to Cognitive Market Research, the global industrial hemp in medical market size was estimated at USD XX Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 20.5% from 2024 to 2031.
According to Cognitive Market Research, the global industrial hemp in medical market size was estimated at USD XX Million, out of which the Latin America held the market share of around 5% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 17.9% from 2024 to 2031.
According to Cognitive Market Research, the global industrial hemp in medical market size was estimated at USD XX Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD XX million in 2024 and will grow at a compound annual growth rate (CAGR) of 18.2% from 2024 to 2031..
Global Industrial Hemp in Medical Market Report 2025 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Industrial Hemp in Medical Industry growth. Industrial Hemp in Medical market has been segmented with the help of its , Source Outlook:, and others. Industrial Hemp in Medical market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
This report categorizes competitors in the pharmaceutical and healthcare market based on their product offerings and business models. It includes key details such as definitions, benefits, applications, technological advancements, and regional advantages for each type of pharmaceutical product, including small molecule drugs, biologics, and biosimilars.
Market growth figures, such as market share percentages, revenue, and growth rates (e.g., CAGR), are provided for each segment over the specified period (2019-2023). The report covers various segments
of Industrial Hemp in Medical analyzed in this report are as follows:
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Industrial Hemp in Medical Industry. Request a Free Sample PDF!
This report analyzes revenue growth in the pharma and healthcare industry at global, regional, and national levels, highlighting trends and opportunities for each application. It explores how sectors like pharmaceuticals, therapy, and healthcare monitoring use innovations to address healthcare needs. Key factors include market size, revenue contributions, technological advancements (e.g., AI-driven diagnostics), and regulatory considerations. The report also covers the value chain, identifying key players and processes within the industry. For more information, please request a sample or contact our research team.
Some of the key of Industrial Hemp in Medical are:
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
According to Cognitive Market Research, the organic segment holds the largest share of the market due to increasing consumer preference for natural, chemical-free products. Hemp grown without pesticides or synthetic fertilizers is seen as safer and more environmentally friendly. With rising health-consciousness and growing demand for organic wellness products, the market for organic hemp-based medical solutions continues to expand.
In the industrial hemp in medical market, the conventional has been expanding at a rapid pace due to its cost-effectiveness and established farming practices. Conventional hemp cultivation allows for large-scale production, making it more accessible to a wider audience. As the demand for hemp-based products rises, the conventional farming method ensures a steady supply, facilitating the growth of this segment in the medical market.
Senior Research Associate at Cognitive Market Research
Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.
Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over three years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies.
In her current role, Manjiri handles the market research related to Pharma and healthcare industry. Her passion lies in utilizing innovative approaches to distill complex information into strategic insights that empower organizations to make informed decisions.Manjiri remains an invaluable asset in the dynamic landscape of market research.
Conclusion
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Disclaimer:
Source Outlook: | Conventional, Organic |
List of Competitors | Charlotte's Web, Canopy Growth Corporation, Aurora Cannabis Inc., Tilray Inc., HempMeds, Elixinol Global Limited, Medterra CBD, CBDistillery, HEXO Corp, GW Pharmaceuticals, Pure Hemp Botanicals, Endoca, American Green Inc., The Green Organic Dutchman, Vitality CBD |
This chapter will help you gain GLOBAL Market Analysis of Industrial Hemp in Medical. Further deep in this chapter, you will be able to review Global Industrial Hemp in Medical Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
This chapter will help you gain North America Market Analysis of Industrial Hemp in Medical. Further deep in this chapter, you will be able to review North America Industrial Hemp in Medical Market Split by various segments and Country Split.
Chapter 2 North America Market Analysis
This chapter will help you gain Europe Market Analysis of Industrial Hemp in Medical. Further deep in this chapter, you will be able to review Europe Industrial Hemp in Medical Market Split by various segments and Country Split.
Chapter 3 Europe Market Analysis
This chapter will help you gain Asia Pacific Market Analysis of Industrial Hemp in Medical. Further deep in this chapter, you will be able to review Asia Pacific Industrial Hemp in Medical Market Split by various segments and Country Split.
Chapter 4 Asia Pacific Market Analysis
This chapter will help you gain South America Market Analysis of Industrial Hemp in Medical. Further deep in this chapter, you will be able to review South America Industrial Hemp in Medical Market Split by various segments and Country Split.
Chapter 5 South America Market Analysis
This chapter will help you gain Middle East Market Analysis of Industrial Hemp in Medical. Further deep in this chapter, you will be able to review Middle East Industrial Hemp in Medical Market Split by various segments and Country Split.
Chapter 6 Middle East Market Analysis
This chapter will help you gain Middle East Market Analysis of Industrial Hemp in Medical. Further deep in this chapter, you will be able to review Middle East Industrial Hemp in Medical Market Split by various segments and Country Split.
Chapter 7 Africa Market Analysis
This chapter provides an in-depth analysis of the market share among key competitors of Industrial Hemp in Medical. The analysis highlights each competitor's position in the market, growth trends, and financial performance, offering insights into competitive dynamics, and emerging players.
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
This chapter would comprehensively cover market drivers, trends, restraints, opportunities, and various in-depth analyses like industrial chain, PESTEL, Porter’s Five Forces, and ESG, among others. It would also include product life cycle, technological advancements, and patent insights.
Chapter 9 Qualitative Analysis (Subject to Data Availability)
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Source Outlook: Analysis 2021 - 2033
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Industrial Hemp in Medical market
Chapter 11 Research Findings
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Chapter 12 Research Methodology and Sources
Why have a significant impact on Industrial Hemp in Medical market? |
What are the key factors affecting the and of Industrial Hemp in Medical Market? |
What is the CAGR/Growth Rate of during the forecast period? |
By type, which segment accounted for largest share of the global Industrial Hemp in Medical Market? |
Which region is expected to dominate the global Industrial Hemp in Medical Market within the forecast period? |
Segmentation Level Customization |
|
Global level Data Customization |
|
Region level Data Customization |
|
Country level Data Customization |
|
Company Level |
|
Additional Data Analysis |
|
Additional Qualitative Data |
|
Additional Quantitative Data |
|
Service Level Customization |
|
Report Format Alteration |
|